Molecular Templates, Inc.
(NASDAQ : MTEM)

( )
MTEM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.12%200.811.2%$402.10m
GILDGilead Sciences, Inc.
0.01%72.790.9%$394.52m
CELGCelgene Corporation
0.18%87.361.2%$339.76m
BIIBBiogen Inc.
-1.26%334.401.2%$273.97m
ILMNIllumina, Inc.
-1.67%347.223.5%$252.24m
REGNRegeneron Pharmaceuticals, Inc.
-1.45%386.492.6%$210.24m
EXASExact Sciences Corporation
0.00%73.3325.3%$198.68m
VRTXVertex Pharmaceuticals Incorporated
-1.79%175.801.9%$159.87m
SRPTSarepta Therapeutics, Inc.
-0.27%152.3516.4%$124.87m
AAgilent Technologies, Inc.
0.33%69.081.5%$121.49m
ALXNAlexion Pharmaceuticals, Inc.
-0.33%117.812.0%$107.50m
ALNYAlnylam Pharmaceuticals, Inc
-3.90%93.359.7%$95.81m
NKTRNektar Therapeutics
-1.48%57.455.6%$94.55m
BMRNBioMarin Pharmaceutical Inc.
-1.27%98.154.4%$90.68m
INCYIncyte Corporation
-1.57%67.022.5%$87.71m

Company Profile

Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics for the treatment of cancers and other serious diseases. The company was founded on August 1, 2017 and is headquartered in Austin, TX.